| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/08/2004 | US20040005686 Crystalline structure of human MAPKAP kinase-2 |
| 01/08/2004 | US20040005683 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 01/08/2004 | US20040005666 Methods and reagents for modulating cholesterol levels |
| 01/08/2004 | US20040005664 Novel 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 and 8843 molecules and uses therefor |
| 01/08/2004 | US20040005655 Comprises nucleotides equences coding enzymatic polypeptides for destroying or detecting hydrogen peroxide and producing glyoxylic acid; bleaching; bactericide; papermaking |
| 01/08/2004 | US20040005653 Methods and devices for the detection of pathogenic microorganisms and their antimicrobial susceptibility |
| 01/08/2004 | US20040005652 Nutrient base to facilitate growth of Bacillus cereus, Bacillus thuringiensis and Bacillus anthrasis, chromogenic substrate that changes color responsive to presence of PC-PLC enzymes, ingredient that promotes expression of enzymes |
| 01/08/2004 | US20040005651 Method for metal analysis and speciation and biosensor for effecting the method |
| 01/08/2004 | US20040005650 Identifying enzyme modulators for treating neurodegenerative, autoimmune and tumor diseases |
| 01/08/2004 | US20040005648 PYK2 related products and methods |
| 01/08/2004 | US20040005634 System and method for determining differential protein expression, diagnostic biomarker discovery system and method of using the same, and protein biomarkers and therapeutic and diagnostic uses thereof |
| 01/08/2004 | US20040005632 Use of "tethering"; compounds can be in the form of an individual enantiomer, diasteromer, geometric isomer, or mixtures thereof; for drug discovery |
| 01/08/2004 | US20040005629 Natural ligand of orphan G protein coupled receptor GPR86 and methods of use |
| 01/08/2004 | US20040005625 Producing CDNA gene expression profile based on electrophoretic mobility |
| 01/08/2004 | US20040005624 84573, a human protein kinase family member and uses therefor |
| 01/08/2004 | US20040005623 Monitoring and evaluating efficacy of antitumor agents destroying cancer cells; enzyme inhibitors; in vitro drug screening |
| 01/08/2004 | US20040005622 Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers |
| 01/08/2004 | US20040005621 Method of determining a chemotherapeutic regimen based on ERCC1 expression |
| 01/08/2004 | US20040005620 Probe medium |
| 01/08/2004 | US20040005619 Diagnosing osteoporosis and paget's diseases via identifying variable numbers of tandem repeats in allelic sequences coding parathyroid hormone related peptide (PTHrP) |
| 01/08/2004 | US20040005618 Detecting antisense oligonucleotides 20 to 30 nucleobases in length in a bodily fluid or extract; colorimetric analysis |
| 01/08/2004 | US20040005617 Diagnosing brain and ovarian cancer via presence of allelic variance in gene associated with serine protease inhibitors (SERPINB13); restriction fragment length polymorphisms |
| 01/08/2004 | US20040005616 Separating and extracting nucleotide sequences using polyethylene glycol and dextran |
| 01/08/2004 | US20040005615 Amplification and overexpression of oncogenes |
| 01/08/2004 | US20040005614 Labeling, fragmenting and immobilizing polynucleotides; genome analysis |
| 01/08/2004 | US20040005613 Detecting restriction fragment length polymorphisms associated with allelic mutation using peptide nucleic acids |
| 01/08/2004 | US20040005612 Detecting gene expression products transcribed during window of implantation and downregulated during endometriosis; contraceptives; treating sex disorders; drug screening |
| 01/08/2004 | US20040005611 PNA probes, probe sets, methods and kits pertaining to the determination of Listeria |
| 01/08/2004 | US20040005610 Computational determination of alternative splicing |
| 01/08/2004 | US20040005609 Methods and kits for indirect labeling of nucleic acids |
| 01/08/2004 | US20040005607 Bis-diazo,triaryl and aryldiazo-N-arylphenazonium quencher moieties, substituted with electron withdrawing, electron donating substituents which induce polarity in delocalized aryl/diazo ring system; use as labels attached to biomolecules |
| 01/08/2004 | US20040005606 Fluorometric assay for detecting nucleic acid cleavage |
| 01/08/2004 | US20040005605 Determining content ratio of genetic recombinant in a sample |
| 01/08/2004 | US20040005604 Comprises nucleotide sequences coding enzymatic polypeptide for degumming oil and food processing; antisense therapy |
| 01/08/2004 | US20040005601 Identifying modulators of quadruplex DNA activity; drug delivery; cancer diagnosis; antitumor agents |
| 01/08/2004 | US20040005598 Comprises nucleotide sequences coding protein upregulated in metastatic prostate cancer (PUMPCn) for diagnosis and treatment of tumors; antiproliferative agents; anticarcinogenic agents |
| 01/08/2004 | US20040005597 Comprises nucleotide sequences coding chaperone protein which protects enzymes and cellular systems in extreme heat; polymerase chain reaction; preventing enzymatic aggregation and intracellular precipitation during heat stress |
| 01/08/2004 | US20040005596 Gene amplification in cancer |
| 01/08/2004 | US20040005595 Inversion probes |
| 01/08/2004 | US20040005594 Identifying and characterizing modulators of nucleic acid processing enzymes; enzyme inhibitors |
| 01/08/2004 | US20040005592 Materials and methods relating to therapy and diagnosis using targeting of cells that express DCAL-Hy polypeptides |
| 01/08/2004 | US20040005589 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 01/08/2004 | US20040005587 Protein activity screening of clones having DNA from uncultivated microorganisms |
| 01/08/2004 | US20040005585 Polynucleotide sequence assay |
| 01/08/2004 | US20040005584 Biallelic markers for use in constructing a high density disequilibrium map of the human genome |
| 01/08/2004 | US20040005583 Method for analysing nucleic acids |
| 01/08/2004 | US20040005582 Biospecific desorption microflow systems and methods for studying biospecific interactions and their modulators |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005580 Screening for genetic adjustments in galactose-1-phosphate uridyl transferase (GALT) gene; diagnosing galactosemia-causing genetic modifications |
| 01/08/2004 | US20040005579 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005578 Myocardial cell proliferation-associated genes |
| 01/08/2004 | US20040005577 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005575 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005571 Axs gene and protein and methods related thereto |
| 01/08/2004 | US20040005568 Movement of multi-enzymatic nanoassemblies on recognition landscapes |
| 01/08/2004 | US20040005567 Antisense modulation of cyclin-dependent kinase 4 expression |
| 01/08/2004 | US20040005566 Diagnosing and prognosing cardiovascular disorders via identifying presence of preferential restriction fragment length polymorphisms in genome |
| 01/08/2004 | US20040005565 Antisense modulation of livin expression |
| 01/08/2004 | US20040005564 Methods of identifying synthetic transcriptonal and translational regulatory elements, and compositions relating to same |
| 01/08/2004 | US20040005563 Detecting transcription products associated urogenital cancers drug screening; drug screening; antiproliferative agents |
| 01/08/2004 | US20040005561 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 01/08/2004 | US20040005559 Markers of neuronal differentiation and morphogenesis |
| 01/08/2004 | US20040005555 Molecular diagnosis of bactermia |
| 01/08/2004 | US20040005553 Comprises membrane protein for treating cancer, inflammation and autoimmune disorders |
| 01/08/2004 | US20040005552 Using immunoassays to detecting homopolynucleotide sequences in sample |
| 01/08/2004 | US20040005551 Circulating epstein-barr virus DNA in the serum or plasma of patients for the prediction and detection of epstein-barr virus associated cancers apart from head, neck and lymphoid malignancies |
| 01/08/2004 | US20040005547 Using nucleotide sequences primers and probes for diagnosing liver toxicity |
| 01/08/2004 | US20040005546 Use of ribozymes in the detection of adventitious agents |
| 01/08/2004 | US20040005543 Compositions and methods for binding agglomeration proteins |
| 01/08/2004 | US20040005541 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same |
| 01/08/2004 | US20040005540 Apparatus comprising piezoelectric crystals and genetically engineered phage for screening, identifying and detecting ligand affinities for peptides; screening for anthrax, smallpox or toxins in air; biological warfare agents |
| 01/08/2004 | US20040005325 Helicobacter felis vaccine |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | US20040005313 Use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role |
| 01/08/2004 | US20040005299 Method for producing pseudo islets |
| 01/08/2004 | US20040005294 Insulin-like growth factor binding protein expression can be diagnostic of cancer development and progression. |
| 01/08/2004 | US20040004180 Sensor device |
| 01/08/2004 | DE10228081A1 Verfahren zum Nachweis einer gesteigerten Tumorsuszeptibilität A method for detecting an increased tumor susceptibility |
| 01/08/2004 | DE10226945A1 Feldeffekttransistor auf Basis eines organischen Halbleitermaterials Field-effect transistor based on an organic semiconductor material |
| 01/08/2004 | DE10226675A1 Verfahren zur Testung des hormonellen Effekts von Substanzen Method for testing the hormonal effect of substances |
| 01/08/2004 | DE10226674A1 Verfahren zur Testung des hormonellen Effekts von Substanzen Method for testing the hormonal effect of substances |
| 01/08/2004 | DE10226072A1 Analyseverfahren zur Analyse von spezifischen Bindungsereignissen Analytical methods for analysis of specific binding events |
| 01/08/2004 | CA2527588A1 Disease risk estimating method using sequence polymorphisms in a specific region of chromosome 19 |
| 01/08/2004 | CA2513143A1 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 01/08/2004 | CA2491563A1 Method for detecting mutated polynucleotides within a large population of wild-type polynucleotides |
| 01/08/2004 | CA2491395A1 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 01/08/2004 | CA2491392A1 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 01/08/2004 | CA2491388A1 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 01/08/2004 | CA2491117A1 Methods and compositions for analyzing compromised samples using single nucleotide polymorphism panels |
| 01/08/2004 | CA2491089A1 Compounds useful for the inhibition of aldh |
| 01/08/2004 | CA2490949A1 Method for the characterisation of nucleic acid molecules |
| 01/08/2004 | CA2490918A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 01/08/2004 | CA2490862A1 Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance |
| 01/08/2004 | CA2490766A1 A system and method for snp genotype clustering |
| 01/08/2004 | CA2490765A1 Nano-sized optical fluorescence labels and uses thereof |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490367A1 Therapeutic methods for reducing fat deposition and treating associated conditions |
| 01/08/2004 | CA2490290A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | CA2490283A1 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |